Contribution of pharmacoepidemiological studies to the evaluation of treatment-related adverse events.
Suissa
Samy
S
Division of Clinical Epidemiology, Royal Victoria Hospital, McGill University Health Centre, 687 Pine Avenue West, Ross 4.29 Montreal, Québec, Canada H3A 1A1. samy.suissa@clinepi.mcgill.ca
D018501:Antirheumatic Agents / Q000009:adverse effects*; D052246:Cyclooxygenase 2 Inhibitors / Q000009:adverse effects*; D006801:Humans; D017891:Pharmacoepidemiology; D012216:Rheumatic Diseases / Q000188:drug therapy* / Q000453:epidemiology*; D012307:Risk Factors
D018501:Antirheumatic Agents; D052246:Cyclooxygenase 2 Inhibitors